Exon 6 variants carried on systemic lupus erythematosus (SLE) risk haplotypes modulate IRF5 function

References

• Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, Kano S, Honda K, Ohba Y, Mak TW, Taniguchi T. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature. 2005; 434:243–249.
   PubMed Web of Science ®Google Scholar
• Yanai H, Chen H, Inuzuka T, Kondo S, Mak TW, Takaoka A, Honda K, Taniguchi T. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc Natl Acad Sci USA. 2007; 104:3402–3407.
   PubMed Web of Science ®Google Scholar
• Cheng T, Brzostek S, Ando O, Scoy SV, Kumar KP, Reich NC. Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection. J Immunol. 2006; 176:7462–7470.
   PubMed Web of Science ®Google Scholar
• Graham RR, Kyogoku C, Sigurdsson S, Vlasova IA, Davies LRL, Baechler EC, Plenge RM, Koeuth T, Ortmann WA, Hom G, Bauer JW, Gillett C, Burtt N, Cunninghame Graham DS, Onofrio R, Petri M, Gunnarsson I, Svenungsson E, Ro¨nnblom L, Nordmark G, Gregersen PK, Moser K, Gaffney PM, Criswell LA, Vyse TJ, Syva¨nen AC, Bohjanen PR, Daly MJ, Behrens TW, Altshuler D. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci USA. 2007; 104:6758–6763.
   PubMed Web of Science ®Google Scholar
• Sigurdsson S, Go¨ring HHH, Kristjansdottir G, Milani L, Nordmark G, Sandling JK, Eloranta ML, Feng D, Sangster-Guity N, Gunnarsson I, Svenungsson E, Sturfelt G, Jo¨nsen A, Truedsson L, Barnes BJ, Alm G, Ro¨nnblom L, Syva¨nen AC. Comprehsive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet. 2008; 17:872–881.
   PubMed Web of Science ®Google Scholar
• Hu G, Mancl ME, Barnes BJ. Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death. Cancer Res. 2005; 65:7403–7412.
   PubMed Web of Science ®Google Scholar
• Hu G, Barnes BJ. IRF-5 is mediator of the death receptor-induced apoptotic signaling pathway. J Biol Chem. 2009; 284:2767–2777.
   PubMed Web of Science ®Google Scholar
• Barnes BJ, Moore PA, Pitha PM. Virus-specific activation of novel interferon regulatory fator, IRF-5, results in the induction of distinct interferon α genes. J Biol Chem. 2001; 276:23382–23390.
   PubMed Web of Science ®Google Scholar
• Barnes BJ, Kellum MJ, Pinder KE, Frisancho JA, Pitha PM. Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. Cancer Res. 2003; 63:6424–6431.
   PubMed Web of Science ®Google Scholar
• Yasuda K, Richez C, Maciaszek JW, Agrawal N, Akira S, Marshak-Rothstein A, Rifkin IR. Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. J Immunol. 2007; 178:6876–6885.
   PubMed Web of Science ®Google Scholar
• Negishi H, Ohba Y, Yanai H, Takaoka A, Honma K, Yui K, Matsuyama T, Taniguchi T, Honda K. Negative regulation of Toll-like-receptor signaling by IRF-4. Proc Natl Acad Sci USA. 2005; 102:15989–15994.
   PubMed Web of Science ®Google Scholar
• Mori T, Anazawa Y, Iiizumi M, Fukuda S, Nakamura Y, Arakawa H. Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53. Oncogene. 2002; 21:2914–2918.
   PubMed Web of Science ®Google Scholar
• Barnes BJ, Field AE, Pitha-Rowe PM. Virus-induced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFNA enhanceosome in vivo and transcriptional activity of IFNA genes. J Biol Chem. 2003; 278:16630–16641.
   PubMed Web of Science ®Google Scholar
• Couzinet A, Tamura K, Chen H, Nishimura K, Wang ZC, Morishita Y, Takeda K, Yagita H, Yanai H, Taniguchi T, Tamura T. A cell-type-specific requiredment for IFN regulatory factor (IRF5) in Fas-induced apoptosis. Proc Natl Acad Sci USA. 2008; 105:2556–2561.
   PubMed Web of Science ®Google Scholar
• Levi BZ, Hashmueli S, Gleit-Kielmanowicz M, Azriel A, Meraro D. ICSBP/IRF-8 transactivation: A tale of protein-protein interaction. J Interferon Cytokine Res. 2002; 22:153–160.
   PubMed Web of Science ®Google Scholar
• Dideberg V, Kristjansdottir G, Milani L, Libioulle C, Sigurdsson S, Louis E, Wiman AC, Vermeire S, Rutgeerts P, Belaiche J, Franchimont D, Van Gossum A, Bours V, Syva¨nen AC. An insertion-deletion polymorphism in the interferon regulatory factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Human Mol Genetics. 2007; 16:3008–3016.
   PubMed Web of Science ®Google Scholar
• Samuelson LC, Metzger JM. Isolation and freezing of primary mouse embryonic fibroblasts (MEF) for feeder plates. Cold Spring Harb Protoc. 2006 Issue 2:4482.
   Google Scholar
• Van Der Haegen BA, Shay JW. Immortalization of human mammary epithelial cells by SV40 large T-antigen involves a two step mechanism. In Vitro Cell Dev Biol. 1993; 29A:180–182.
   PubMed Web of Science ®Google Scholar
• Graham RR, Kozyrev SV, Baechler EC, Linga Reddy PMV, Plenge RM, Bauer JW, Ortmann WA, Koeuth T, Gonza´lez-Escribano MF, Pons-Estel B, Petri M, Daly M, Gregersen PK, Martín J, Altshuler D, Behrens TW, Alarco´n-Riquelme ME, the Argentine and Spanish Collaborative Groups. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nature Genetics. 2006; 38:550–555.
   PubMed Web of Science ®Google Scholar
• Mancl ME, Hu G, Sangster-Guity N, Olshalsky SL, Hoops K, Fitzgerald-Bocarsly P, Pitha PM, Pinder K, Barnes BJ. Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. J Biol Chem. 2005; 280:21078–21090.
   PubMed Web of Science ®Google Scholar
• Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis: Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J Immunol Meth. 1995; 184 1: 39–51.
   PubMed Web of Science ®Google Scholar
• Barnes BJ, Kellum MJ, Field AE, Pitha PM. Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol Cell Biol. 2002; 22 16: 5721–5740.
   PubMed Web of Science ®Google Scholar
• Lin R, Yang L, Arguello M, Penafuerte C, Hiscott J. A CRM1-dependent nuclear export pathway is involved in the regulation of IRF-5 subcellular localization. J Biol Chem. 2005; 280 4: 3088–3095.
   PubMed Web of Science ®Google Scholar
• Yang L, Zhao T, Shi X, Nakhaei P, Wang Y, Sun Q, Hiscott J, Lin R. Functional analysis of a dominant negative mutation of interferon regulatory factor 5. PLoS ONE. 2009; 4 5: e5500 doi:10.1371/journal.pone.0005500.
   Web of Science ®Google Scholar
• Koyzyrev SV, Lewe´n S, Linga Reddy PMV, Pons-Estel B, Witte T, Junker P, Laustrup P, Gutie´rrez C, Sua´rez A, Gonza´lez-Escribano MF, Martín J, Alarco´n-Riquelme, and the Spanish Collaborative Group. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheumat. 2007; 56 4: 1234–1241.
   PubMedGoogle Scholar